Zimmer Biomet Holdings, Inc. (ZBH)
ZBH moved a median of +0.11% 30 minutes after news, and +0.22% by the close. How ZBH actually reacts to news — the realized, point-in-time move the market made, measured across 634 labeled events over the last three years with zero look-ahead.
ZBH’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | +0.06% | 59% | 633 |
| 30-min | +0.11% | 59% | 634 |
| 60-min | +0.07% | 54% | 634 |
| to close | +0.22% | 61% | 626 |
| Middle 50% of ZBH reactions | -0.31% to +0.52% |
|---|---|
| Median reaction (30-min) | +0.11% |
| Measured reactions | 634 |
Half of all Zimmer Biomet Holdings, Inc. news events land between -0.31% and +0.52% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How ZBH reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades | 25 | +0.55% | 56% | +0.27% |
| Analyst downgrades | 24 | +0.34% | 54% | +0.13% |
| Coverage initiations | 21 | -0.10% | 24% | +0.43% |
| Rating reiterations | 147 | -0.03% | 47% | -0.17% |
| Price-target raises | 23 | +0.14% | 74% | +0.23% |
| Price-target cuts | 50 | +0.08% | 56% | +0.25% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. See how ZBH ranks against every other measured name →
That’s how ZBH usually reacts — get an email when it moves on news →Email me when ZBH moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to ZBH's baseline. Nothing else.
Recent ZBH events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| ZIMMER BIOMET AND THINK SURGICAL EXTEND EXCLUSIVE DISTRIBUTION AGREEMENT | Press release | PR Newswire | +0.73% | -0.85% | |
| Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2026 Financial Results | Press release | PR Newswire | +0.14% | -1.89% | |
| Form 8-K ZIMMER BIOMET HOLDINGS, For: Sep 08 | SEC filing · Form 8-K | SEC EDGAR | +0.44% | +1.71% | |
| Zimmer Biomet Announces Americas Leadership Promotions to Accelerate Commercial Transformation | Press release | PR Newswire | +0.44% | +1.71% | |
| Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2026 | Press release | PR Newswire | -0.33% | -0.16% | |
| Form 10-Q ZIMMER BIOMET HOLDINGS, For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.29% | -1.63% | |
| Form 8-K ZIMMER BIOMET HOLDINGS, For: Aug 05 | SEC filing · Form 8-K | SEC EDGAR | -0.72% | -2.81% | |
| Zimmer Biomet Announces Second Quarter 2026 Financial Results | Press release | PR Newswire | -0.72% | -2.81% | |
| Zimmer Biomet Names Chintan Desai President of Asia Pacific Region | Press release | PR Newswire | -2.88% | -0.51% | |
| Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results | Press release | PR Newswire | +0.56% | +2.61% | |
| Form 8-K ZIMMER BIOMET HOLDINGS, For: Jun 26 | SEC filing · Form 8-K | SEC EDGAR | -1.54% | -3.88% | |
| Zimmer Biomet to Present at the Goldman Sachs 47th Annual Global Healthcare Conference | Press release | PR Newswire | +0.00% | +1.15% | |
| Form 8-K ZIMMER BIOMET HOLDINGS, For: May 22 | SEC filing · Form 8-K | SEC EDGAR | -0.06% | +0.72% | |
| Form SD ZIMMER BIOMET HOLDINGS, | SEC filing · Form SD | SEC EDGAR | -0.06% | +0.72% | |
| Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2026 | Press release | PR Newswire | +0.04% | -1.02% | |
| Form 8-K ZIMMER BIOMET HOLDINGS, For: May 12 | SEC filing · Form 8-K | SEC EDGAR | +0.28% | +2.93% | |
| Zimmer Biomet Increases Share Repurchase Expectations -- Up to $1 Billion by Year End | Press release | PR Newswire | +0.28% | +2.93% | |
| Zimmer Biomet to Present at the BofA Securities 2026 Health Care Conference | Press release | PR Newswire | -0.12% | -1.06% | |
| Form 10-Q ZIMMER BIOMET HOLDINGS, For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.56% | +0.21% | |
| Form 8-K ZIMMER BIOMET HOLDINGS, For: Apr 22 | SEC filing · Form 8-K | SEC EDGAR | +0.82% | -4.83% | |
| Form 8-K ZIMMER BIOMET HOLDINGS, For: Apr 28 | SEC filing · Form 8-K | SEC EDGAR | +0.82% | -4.83% | |
| Zimmer Biomet Announces Chief Financial Officer Transition | Press release | PR Newswire | +0.82% | -4.83% | |
| Zimmer Biomet Announces First Quarter 2026 Financial Results | Press release | PR Newswire | +0.82% | -4.83% | |
| Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2026 Financial Results | Press release | PR Newswire | +0.17% | +0.43% | |
| Zimmer Biomet Appoints Dr. Jonathan M. Vigdorchik as Chief Science, Technology and Medical Affairs Officer | Press release | PR Newswire | +0.08% | +0.01% | |
| Form ARS ZIMMER BIOMET HOLDINGS, For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | -0.03% | +0.56% | |
| Form DEF 14A ZIMMER BIOMET HOLDINGS, For: May 22 | SEC filing · Form DEF | SEC EDGAR | -0.03% | +0.56% | |
| Form DEFA14A ZIMMER BIOMET HOLDINGS, | SEC filing · Form DEFA14A | SEC EDGAR | -0.03% | +0.56% | |
| Zimmer Biomet Wins Three Awards at Healthcare Asia Medtech Awards 2026 | Press release | PR Newswire | -0.65% | -0.69% | |
| Zimmer Biomet to Release New Data, Highlight Key Innovations at American Academy of Orthopaedic Surgeons Annual Meeting | Press release | PR Newswire | +0.29% | -0.15% | |
| Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2026 | Press release | PR Newswire | +0.36% | +0.78% | |
| Form 10-K ZIMMER BIOMET HOLDINGS, For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -0.13% | +0.07% | |
| Form 8-K ZIMMER BIOMET HOLDINGS, For: Feb 10 | SEC filing · Form 8-K | SEC EDGAR | -1.81% | -2.92% | |
| Zimmer Biomet Announces Fourth Quarter and Full-Year 2025 Financial Results | Press release | PR Newswire | -1.81% | -2.92% | |
| Zimmer Biomet Announces Webcast and Conference Call of Fourth Quarter 2025 Financial Results | Press release | PR Newswire | +0.01% | -0.62% | |
| Form 8-K ZIMMER BIOMET HOLDINGS, For: Jan 08 | SEC filing · Form 8-K | SEC EDGAR | -1.44% | -1.59% | |
| Zimmer Biomet to Present at the 44th Annual J.P. Morgan Healthcare Conference | Press release | PR Newswire | +0.59% | +1.11% | |
| Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2025 | Press release | PR Newswire | +0.64% | +1.11% | |
| Zimmer Biomet, OneStep Collaborate to Provide Enhanced Mobility Data to Patients and Surgeons to Help Improve Joint Procedure Recovery | Press release | PR Newswire | +0.10% | -0.88% | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Zimmer Biomet Holdings, Inc. (ZBH) and Encourages Shareholders to Learn More About the Investigation | Press release | ACCESS Newswire | +0.04% | +1.67% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Zimmer Biomet Holdings, Inc. (ZBH) Shareholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | +0.33% | +0.36% | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating Zimmer Biomet Holdings, Inc. (ZBH) And Encourages Shareholders to Connect | Press release | ACCESS Newswire | +0.07% | +0.49% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Zimmer Biomet Holdings, Inc. (ZBH) Stockholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | +0.13% | +0.21% | |
| Zimmer Biomet Holdings, Inc. (ZBH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | +0.12% | -1.17% | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Zimmer Biomet Holdings, Inc. (ZBH) and Encourages Stockholders to Learn More About the Investigation | Press release | ACCESS Newswire | -0.18% | +0.24% | |
| Zimmer Biomet Receives U.S. FDA Clearance for Enhanced Version of ROSA® Knee Robotic Technology | Press release | PR Newswire | -0.36% | -1.10% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Zimmer Biomet Holdings, Inc. (ZBH) Investors to Inquire about Securities Investigation | Press release | ACCESS Newswire | +0.22% | — | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Zimmer Biomet Holdings, Inc. (ZBH) And Encourages Stockholders to Reach Out | Press release | ACCESS Newswire | -0.33% | +0.77% | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating Zimmer Biomet Holdings, Inc. (ZBH) And Encourages Stockholders to Connect | Press release | ACCESS Newswire | -0.08% | +0.97% | |
| Zimmer Biomet to Present at the Annual Jefferies Global Healthcare Conference in London | Press release | PR Newswire | -0.07% | -0.56% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the ZBH section they belong to.
Where else ZBH is measured.
ZBH earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| MYOKARDIA (MYOK) | 635 | -0.01% | 45% |
| Novan, Inc. (NOVN) | 634 | -0.02% | 45% |
| Incyte Corporation (INCY) | 633 | +0.05% | 53% |
| BIOSPECIFICS TECHNOLOGIES (BSTC) | 632 | 0.00% | 43% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Zimmer Biomet Holdings, Inc.'s median reaction calculated?
Every labeled ZBH news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 634 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 59% of ZBH's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does ZBH's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.